Search research articles
Contact Us
Filters
Showing results (31-40 of 73) with videos related to
Page
of 8
Sort By:
Cancer Diagnosis & Prognosis
|
January 5, 2026
Methionine Restriction Must Be Continuously Maintained to Selectively Inhibit Cancer Cells Co-cultured With Normal Cells
Byung Mo Kang, Qinghong Han, Shukuan Li, et al.
In Vivo (Athens, Greece)
|
April 30, 2024
Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine Diet
Motokazu Sato, Qinghong Han, Kohei Mizuta, et al.
Cancer Genomics & Proteomics
|
June 29, 2024
Expression of PD-L1 Is Increased by Methionine Restriction Using Recombinant Methioninase in Human Colorectal Cancer Cells
Kohei Mizuta, Byung Mo Kang, Qinghong Han, et al.
Cancer Diagnosis & Prognosis
|
July 4, 2024
The Combination of Methionine Restriction and Docetaxel Synergistically Arrests Androgen-independent Prostate Cancer But Not Normal Cells
Kohei Mizuta, Ryosuke Mori, Qinghong Han, et al.
Anticancer Research
|
March 27, 2024
Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet
Motokazu Sato, Qinghong Han, Ryosuke Mori, et al.
Anticancer Research
|
August 28, 2025
Combinations of <i>Salmonella typhimurium</i> A1-R, Recombinant Methioninase, and Chloroquine, Each Targeting Fundamental Cancer Hallmarks, Are Selectively Effective on Colon Cancer Cells Compared to Normal Fibroblasts
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
August 28, 2024
[<sup>11</sup>C]Methionine PET <i>vs</i>. [<sup>18</sup>F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients
Motokazu Sato, Toshihiko Sato, Chihiro Hozumi, et al.
Anticancer Research
|
August 28, 2024
First-line Chemotherapy in Combination With Oral Recombinant Methioninase and a Low-methionine Diet for a Stage IV Inoperable Pancreatic-Cancer Patient Resulted in 40% Tumor Reduction and an 86% CA19-9 Biomarker Decrease
Motokazu Sato, Qinghong Han, Chihiro Hozumi, et al.
Anticancer Research
|
December 30, 2025
Methionine Restriction, Not Cysteine Restriction, Is a Cancer-specific Vulnerability
Yuta Miyashi, Kohei Mizuta, Yohei Asano, et al.
Anticancer Research
|
March 27, 2026
The Glucose and Glutamine Requirements of Cancer and Normal Cells Do Not Distinguish Them, in Contrast to Their Methionine Requirement, Suggesting the Warburg Effect Is Not a Cancer Paradigm
Yuta Miyashi, Kohei Mizuta, Tomoyuki Ishiguro, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 73) with videos related to
Sort By:
Page
of 8
Cancer Diagnosis & Prognosis
|
January 5, 2026
Methionine Restriction Must Be Continuously Maintained to Selectively Inhibit Cancer Cells Co-cultured With Normal Cells
Byung Mo Kang, Qinghong Han, Shukuan Li, et al.
In Vivo (Athens, Greece)
|
April 30, 2024
Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine Diet
Motokazu Sato, Qinghong Han, Kohei Mizuta, et al.
Cancer Genomics & Proteomics
|
June 29, 2024
Expression of PD-L1 Is Increased by Methionine Restriction Using Recombinant Methioninase in Human Colorectal Cancer Cells
Kohei Mizuta, Byung Mo Kang, Qinghong Han, et al.
Cancer Diagnosis & Prognosis
|
July 4, 2024
The Combination of Methionine Restriction and Docetaxel Synergistically Arrests Androgen-independent Prostate Cancer But Not Normal Cells
Kohei Mizuta, Ryosuke Mori, Qinghong Han, et al.
Anticancer Research
|
March 27, 2024
Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet
Motokazu Sato, Qinghong Han, Ryosuke Mori, et al.
Anticancer Research
|
August 28, 2025
Combinations of <i>Salmonella typhimurium</i> A1-R, Recombinant Methioninase, and Chloroquine, Each Targeting Fundamental Cancer Hallmarks, Are Selectively Effective on Colon Cancer Cells Compared to Normal Fibroblasts
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
August 28, 2024
[<sup>11</sup>C]Methionine PET <i>vs</i>. [<sup>18</sup>F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients
Motokazu Sato, Toshihiko Sato, Chihiro Hozumi, et al.
Anticancer Research
|
August 28, 2024
First-line Chemotherapy in Combination With Oral Recombinant Methioninase and a Low-methionine Diet for a Stage IV Inoperable Pancreatic-Cancer Patient Resulted in 40% Tumor Reduction and an 86% CA19-9 Biomarker Decrease
Motokazu Sato, Qinghong Han, Chihiro Hozumi, et al.
Anticancer Research
|
December 30, 2025
Methionine Restriction, Not Cysteine Restriction, Is a Cancer-specific Vulnerability
Yuta Miyashi, Kohei Mizuta, Yohei Asano, et al.
Anticancer Research
|
March 27, 2026
The Glucose and Glutamine Requirements of Cancer and Normal Cells Do Not Distinguish Them, in Contrast to Their Methionine Requirement, Suggesting the Warburg Effect Is Not a Cancer Paradigm
Yuta Miyashi, Kohei Mizuta, Tomoyuki Ishiguro, et al.
Page
of 8